Molecular profile of liquid biopsies: Next generation biomarkers to improve lung cancer treatment

3Citations
Citations of this article
28Readers
Mendeley users who have this article in their library.

Abstract

Molecular profiling of liquid biopsies is now emerging as pivotal for cancer biomarker discovery. The low-invasive nature of the approach used for collecting biospecimens (i.e. blood, urine, saliva, etc.) may allow a widespread application of novel molecular diagnostics based on liquid biopsies. This is relevant, for example, in cancer screening programmes where it is essential to reduce costs and the complexity of screening tests in order to increase study compliance and effectiveness. Here, I discuss recent advances in biomarkers for the early cancer detection and prediction of chemotherapy response based on the molecular profiling of liquid biopsies.

Cite

CITATION STYLE

APA

Bianchi, F. (2015). Molecular profile of liquid biopsies: Next generation biomarkers to improve lung cancer treatment. Ecancermedicalscience, 9. https://doi.org/10.3332/ecancer.2015.598

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free